We are live on
!
Find out more
BBA
BLB&B Advisors Portfolio holdings
AUM
$2.73B
Turnover
8.25%
1-Year Est. Return
25.76%
This Fund
S&P 500
This Quarter
Est. Return
-4.29%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$1.49B
AUM Growth
-$51M
(-3.3%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
42.49%
Holding
262
New
7
Increased
79
Reduced
130
Closed
12
Avg Time Held
5.9
years
Top 10 Avg Time Held
3.5
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$6.25M |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
+$5.54M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$5.24M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.77M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$3.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$4.22M |
| 2 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$1.85M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.73M |
| 4 |
3M
MMM
|
+$696K |
| 5 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$633K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 11.63% |
| 3 | Healthcare | 7.52% |
| 4 | Financials | 6.65% |
| 5 | Consumer Staples | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
AGNC Investment
AGNC
$10.3B
| – | – |
-10,250
| Closed | -$154K | – |
|
252
AstraZeneca
AZN
$256B
| – | – |
-2,888
| Closed | -$336K | – |
|
253
Biogen
BIIB
$34.6B
| – | – |
-843
| Closed | -$202K | – |
|
254
Darden Restaurants
DRI
$24.4B
| – | – |
-1,650
| Closed | -$249K | – |
|
255
Quaker Houghton
KWR
$2.72B
| – | – |
-1,000
| Closed | -$231K | – |
|
256
Alliant Energy
LNT
$17.6B
| – | – |
-3,529
| Closed | -$217K | – |
|
257
Thermo Fisher Scientific
TMO
$255B
| – | – |
-337
| Closed | -$225K | – |
|
258
Unilever
UL
$142B
| – | – |
-8,008
| Closed | -$485K | – |
|
259
UnitedHealth
UNH
$360B
| – | – |
-440
| Closed | -$221K | – |
|
260
Waters Corp
WAT
$42.7B
| – | – |
-600
| Closed | -$224K | – |
|
|
RDS.A
261
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-9,221
| Closed | -$400K | – |
|
Similar funds
MAS
ACM
CIAS
LIM
SIG
AGA
GXJ
TAM
BLB&B Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, BLB&B Advisors held 262 positions worth $1.49B, down 3.3% from $1.54B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BLB&B Advisors's Q1 2022 filing shows 7 new, 79 increased, 130 reduced and 12 closed positions. Its largest new stake was Vanguard Information Technology ETF: 31,224 shares worth $1.63M. The largest sale was SLB Ltd, an estimated $4.22M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.
- BLB&B Advisors's largest Q1 2022 buy was Vanguard Information Technology ETF: 31,224 shares worth $1.63M.
- BLB&B Advisors added most to iShares Core MSCI Emerging Markets ETF in Q1 2022, an estimated $6.25M increase.
- BLB&B Advisors's biggest Q1 2022 reduction was SLB Ltd, cutting an estimated $4.22M.
- BLB&B Advisors fully exited Unilever in Q1 2022, selling an estimated $485K.
- BLB&B Advisors's ten largest holdings make up 42% of its $1.49B portfolio in Q1 2022.
- BLB&B Advisors opened 7 new positions and closed 12 in Q1 2022.
- BLB&B Advisors's portfolio value fell 3.3% quarter-over-quarter to $1.49B.
Based on BLB&B Advisors's 13F filing for Q1 2022, filed 20 Apr 2022.